Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256,792 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment.
Wang Y, Drum DL, Sun R, Zhang Y, Chen F, Sun F, Dal E, Yu L, Jia J, Arya S, Jia L, Fan S, Isakoff SJ, Kehlmann AM, Dotti G, Liu F, Zheng H, Ferrone CR, Taghian AG, DeLeo AB, Ventin M, Cattaneo G, Li Y, Jounaidi Y, Huang P, Maccalli C, Zhang H, Wang C, Yang J, Boland GM, Sadreyev RI, Wong L, Ferrone S, Wang X. Wang Y, et al. Among authors: zhang h, zhang y. Nat Commun. 2023 Sep 15;14(1):5727. doi: 10.1038/s41467-023-41282-x. Nat Commun. 2023. PMID: 37714830 Free PMC article.
Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells.
Zhang Y, He L, Sadagopan A, Ma T, Dotti G, Wang Y, Zheng H, Gao X, Wang D, DeLeo AB, Fan S, Sun R, Yu L, Zhang L, Wang G, Ferrone S, Wang X. Zhang Y, et al. Among authors: zhang l. Mol Cancer Ther. 2021 Mar;20(3):577-588. doi: 10.1158/1535-7163.MCT-20-0446. Mol Cancer Ther. 2021. PMID: 33653946 Free PMC article.
Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
Wang X, Guo W, Jia L, Xie L, Kiang J, Wang Y, Wang F, Lin Z, Wang E, Zhang Y, Huang P, Sun T, Zhang X, Bian Z, Tang T, Guo J, Ferrone S. Wang X, et al. Among authors: zhang x, zhang y. Res Sq [Preprint]. 2023 Aug 18:rs.3.rs-3195392. doi: 10.21203/rs.3.rs-3195392/v1. Res Sq. 2023. Update in: Cell Death Dis. 2024 Apr 27;15(4):298. doi: 10.1038/s41419-024-06644-3. PMID: 37645899 Free PMC article. Updated. Preprint.
Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
Guo W, Jia L, Xie L, Kiang JG, Wang Y, Sun F, Lin Z, Wang E, Zhang Y, Huang P, Sun T, Zhang X, Bian Z, Tang T, Guo J, Ferrone S, Wang X. Guo W, et al. Among authors: zhang x, zhang y. Cell Death Dis. 2024 Apr 27;15(4):298. doi: 10.1038/s41419-024-06644-3. Cell Death Dis. 2024. PMID: 38678042 Free PMC article.
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
Mei S, Alchahin AM, Tsea I, Kfoury Y, Hirz T, Jeffries NE, Zhao T, Xu Y, Zhang H, Sarkar H, Wu S, Subtelny AO, Johnsen JI, Zhang Y, Salari K, Wu CL, Randolph MA, Scadden DT, Dahl DM, Shin J, Kharchenko PV, Saylor PJ, Sykes DB, Baryawno N. Mei S, et al. Among authors: zhang h, zhang y. Genome Med. 2024 Jan 29;16(1):1. doi: 10.1186/s13073-023-01272-6. Genome Med. 2024. PMID: 38281962 Free PMC article.
Rules all PIs should follow.
Chen JS, Huang CY, Lanke S, Fernandopulle MS, Ji Y, Zhi Y, Rodríguez SG, Frommel AY, Lukačišin M, Zhang Y, Zdenek CN, Wu XY, Seenuvasaragavan S, Zhuang Y, Bergh C, Coulbois J, Salloum-Asfar S, Cao B, Davis K, Oda F, Konstantinides N, Zhang L; Name withheld; Agarwal D, Rainaldi JN, Kadlec J, Vekeman J, Kanigicherla VA, Oi K, Isaacson KJ, Ganji R, Dawson-Glass E. Chen JS, et al. Among authors: zhang l, zhang y. Science. 2022 Apr;376(6588):24-26. doi: 10.1126/science.abp9887. Epub 2022 Mar 31. Science. 2022. PMID: 35357910 No abstract available.
256,792 results
You have reached the last available page of results. Please see the User Guide for more information.